BevCanna Announces Strong Third Quarter 2021 Financial Results
BevCanna Announces Strong Third Quarter 2021 Financial Results
Increases revenues by more than 1000 per cent over the comparable quarter of 2020
与2020年可比季度相比,收入增加了1000%以上
VANCOUVER, British Columbia--(BUSINESS WIRE)--BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) ("BevCanna" or the "Company"), an emerging leader in innovative health and wellness beverages and products, today reported its unaudited financial results for the quarter ended September 30, 2021.
加拿大不列颠哥伦比亚省温哥华--(美国商业资讯)--BevCanna Enterprise Inc.(CSE:BIV,Q:BVNNF,FSE:7BC)(以下简称“BevCanna”或“公司”)今天公布了截至2021年9月30日的季度未经审计的财务业绩。
Third Quarter Company Highlights (All Amounts Reported in $CAD; Unaudited; prepared in accordance with International Financial Reporting Standards)
第三季度公司要点(所有金额均以加元报告;未经审计;根据国际财务报告准则编制)
- Delivered revenue growth of over 1,000 per cent to $1.1 million during the quarter ended September 30, 2021, compared to $94,000 comparable quarter of 2020
- Gross Profit of $356,168 during the quarter ended September 30, 2021, compared to a loss of $40,280 comparable quarter of 2020
- Cash as of September 30, 2021, of $655,563 compared to $1.0 million as of December 31, 2020
- Announced a definitive agreement to acquire Embark Health Inc. ("Embark"), a leader in solventless cannabis extraction and enhanced delivery technology, with a focus on the formulation and production of advanced cannabis 2.0 products for the B2B, medical and adult-use markets
- Obtained product listings and purchase orders from British Columbia Liquor Distribution Branch (BCLDB), Alberta Gaming and Liquor Commission and Ontario Cannabis Store, and successfully shipped product to British Columbia and Ontario. Subsequent to quarter end, the initial shipment of the award-winning Keef Brands line of cannabis-infused beverages to the BCLDB sold out online
- Announced a definitive agreement with The Tinley Beverage Company Inc. (CSE:TNY, OTCQX:TNYBF) to co-manufacture its award-winning cannabis-infused beverages for the Canadian market
- BevCanna's Naturo Group announced a supply agreement with B.C. Ministry of Forests to supply B.C. firefighters with custom limited-edition TRACE alkaline waters
- Announced that its market-leading TRACE line of natural alkaline spring waters will be the official Water Supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, including the highly anticipated Formula E electric car race, part of the ABB FIA Formula E World Championship series
- 在截至2021年9月30日的季度里,实现了超过1000%的收入增长,达到110万美元,而2020年可比季度为9.4万美元
- 截至2021年9月30日的季度毛利润为356,168美元,而2020年可比季度亏损40,280美元
- 截至2021年9月30日的现金为655,563美元,而截至2020年12月31日的现金为100万美元
- 宣布达成一项最终协议,收购无溶剂大麻提取和增强输送技术领域的领先者Bookk Health Inc.,专注于为B2B、医疗和成人使用市场配制和生产先进的大麻2.0产品
- 从不列颠哥伦比亚省酒类分销分公司(BCLDB)、艾伯塔省博彩和酒类委员会和安大略省大麻商店获得产品清单和采购订单,并成功将产品运往不列颠哥伦比亚省和安大略省。季度结束后,BCLDB的获奖Keef Brands大麻注入饮料系列的首批发货在网上销售一空
- 宣布与Tinley Beverage Company Inc.(CSE:TNY,OTCQX:TNYBF)达成一项最终协议,共同为加拿大市场生产其屡获殊荣的注入大麻的饮料
- BevCanna的Naturo集团宣布与不列颠哥伦比亚省林业部达成供应协议,向不列颠哥伦比亚省消防员提供定制限量版微量碱性水
- 宣布其市场领先的天然碱性泉水痕量线将成为加拿大E-Prix/2022年温哥华E-Prix赛事的官方供水供应商,其中包括备受期待的电动方程式E赛车比赛,这是ABB FIA Formula E世界锦标赛系列的一部分
Recent Highlights (Subsequent to Quarter End)
近期亮点(季度末之后)
- On October 5, 2021, BevCanna's Naturo Group announced that it has finalized an agreement with leading North American wholesaler distributor United Natural Foods, Inc. (UNFI). UNFI Canada will now distribute BevCanna's TRACE line of products to retailers across Canada. The UNFI agreement represents a significant milestone for BevCanna. UNFI Canada is a subsidiary of UNFI, the largest publicly traded wholesale distributor in North America
- On October 7, 2021, BevCanna announced that it has entered into a white-label agreement with Xebra Brands Ltd., a rising player in the global cannabis beverage sector
- On October 14, 2021, the Company announced that it has entered into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products ("Averi"). Averi is a new adult alternative beverage company founded by Terry Donnelly, former CEO of the award-winning Hill Street Beverage Co.
- On October 21, 2021, BevCanna announced that it has been granted an amendment to its Health Canada-authorized Cannabis Research License, to include sensory evaluations of cannabis beverages in its product development trials. This update to the License will allow BevCanna to conduct on-site human assessments of the taste, smell, feel and visual appeal of its products in development, opening significant opportunities in the formulation and refinement of BevCanna's products and those of its white-label clients
- 2021年10月5日,贝弗卡纳的Naturo集团宣布,它已经与北美领先的批发商联合天然食品公司(United Natural Foods,Inc.)敲定了一项协议。FURI加拿大公司现在将向加拿大各地的零售商分销BevCanna的TRACE系列产品。伙伴基金的协议对BevCanna来说是一个重要的里程碑。FURI加拿大公司是北美最大的上市批发分销商FURI的子公司
- 2021年10月7日,BevCanna宣布,它已经与全球大麻饮料行业的后起之秀XEBRA Brands Ltd.达成了一项白标协议
- 2021年10月14日,该公司宣布达成协议,为Averi保健品(“Averi”)生产和分销白标大麻饮料。Averi是一家新的成人另类饮料公司,由获奖的Hill Street Beverage Co.前首席执行官特里·唐纳利(Terry Donnelly)创立。
- 2021年10月21日,BevCanna宣布,它已获得加拿大卫生部授权的大麻研究许可证的修正案,将大麻饮料的感官评估纳入其产品开发试验。许可证的这次更新将允许BevCanna对其正在开发的产品的味道、气味、手感和视觉吸引力进行现场人类评估,为BevCanna及其白标客户的产品的制定和改进提供了重要的机会
Management Commentary
管理评论
"As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000 per cent, achieving $1.1 million in sales, compared to $94,000 in the year ago quarter," commented John Campbell, Chief Financial Officer of BevCanna. "Our third quarter results are further evidence of the Company's continued execution and the impact that our brands are having on the market.
BevCanna首席财务官约翰·坎贝尔评论说:“在第三季度结束时,我们实现了超过1000%的令人印象深刻的收入增长,实现了110万美元的销售额,而去年同期为9.4万美元。”我们第三季度的业绩进一步证明了公司的持续执行力以及我们的品牌对市场的影响。
"Our unique and diverse portfolio continues to expand, and with the impending close of our acquisition of Embark, will include an even wider range of adult-use and wellness channels and innovative product categories," continued Mr. Campbell. "We look forward to welcoming Embark and its team and remain laser-focused on our go-forward organic growth, while continuing to pursue complementary acquisitions, with the goal of further diversifying our brand offerings in the health and wellness categories."
坎贝尔先生继续说:“我们独特和多样化的产品组合继续扩大,随着我们对Bookk的收购即将完成,我们将包括更广泛的成人使用和保健渠道以及创新产品类别。”我们期待着欢迎Bookk及其团队,并继续专注于我们前进的有机增长,同时继续寻求互补性收购,目标是进一步使我们在健康和保健类别中的品牌产品多样化。“
The unaudited consolidated financial statements and Management Discussion and Analysis for the quarter ended September 30, 2021, are available at www.sedar.com.
截至2021年9月30日的季度的未经审计的综合财务报表以及管理层讨论和分析可在www.sedar.com上查阅。
AGM Results: shareholders approved all matters considered at the Company's Annual General and Special Meeting of Shareholders ("AGM") held November 24, 2021.
年度股东大会结果:股东通过了公司2021年11月24日召开的年度股东大会(“年度股东大会”)审议的所有事项。
Voting Results
投票结果
Full details of the matters that were voted on at the AGM of Company shareholders held on November 24, 2021, are set out in the Company's Management Information Circular dated October 25, 2021, which is available on SEDAR.
在2021年11月24日举行的公司股东年度大会上投票表决的事项的全部细节载于本公司日期为2021年10月25日的管理信息通告,该通告可在SEDAR上查阅。
1. Election of Directors
1.董事选举
The following persons were elected to serve as directors of the Company, with the outcome of votes being as follows:
下列人士当选为本公司董事,表决结果如下:
Nominee |
% of Votes for |
% of Votes Withheld | |||||
Marcello Leone |
97.7% |
2.3% | |||||
John Campbell |
97.8% |
2.3% | |||||
Martino Ciambrelli |
97.7% |
2.3% | |||||
Phil Fontaine |
30.1% |
69.9% | |||||
William Macdonald |
98.53% |
1.47% | |||||
Howard Blank |
98.46% |
1.54% | |||||
Douglas Mason |
98.52% |
1.48% |
被提名人 |
得票率: |
被扣留的选票百分比 | |||||
马塞洛·里昂 |
97.7% |
2.3% | |||||
约翰·坎贝尔 |
97.8% |
2.3% | |||||
马蒂诺·钱布雷利 |
97.7% |
2.3% | |||||
菲尔·方丹 |
30.1% |
69.9% | |||||
威廉·麦克唐纳 |
98.53% |
1.47% | |||||
霍华德·布兰克 |
98.46% |
1.54% | |||||
道格拉斯·梅森 |
98.52% |
1.48% |
2. Appointment of Auditor
2.委任核数师
Dale Matheson Carr-Hilton Labonte LLP (DMCL) has been re-appointed as the auditor of the Company for the ensuing year and the Director were authorized to fix the renumeration.
Dale Matheon Carr-Hilton Labonte LLP(DMCL)已再度获委任为本公司下一年度的核数师,董事获授权厘定薪酬。
% Of Votes for |
% of Votes Withheld | ||||
98.34% |
1.66% |
得票率: |
被扣留的选票百分比 | ||||
98.34% |
1.66% |
3. Amendment to Articles
3.修订章程细则
The Company's shareholders also approved an amendment to the Company's articles to create a new class of preferred shares issuable in series as more particularly described in the Management Information Circular.
公司股东还批准了对公司章程的修订,以创建一种新的可系列发行的优先股类别,详情请参阅管理信息通函。
About BevCanna Enterprises Inc.
关于BevCanna企业公司
BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) is a diversified health & wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based, and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing, and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories.
贝夫卡纳企业公司(CSE:BEV,Q:BVNNF,FSE:7BC)是一家多元化的保健饮料和天然产品公司。BevCanna为自有品牌和白标客户开发和生产一系列碱性、植物性和大麻类饮料和补充剂。凭借数十年创建、制造和分销在全球范围内引起消费者共鸣的标志性品牌的经验,该团队在营养食品和注入大麻的饮料类别中展示了无与伦比的专业知识。
Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna's extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands.
总部设在加拿大不列颠哥伦比亚省的BevCanna拥有一个纯净的碱性泉水含水层和一个世界级的4万平方英尺的HACCP认证制造工厂,每年的装瓶能力高达2.1亿瓶。BevCanna广泛的分销网络包括通过其市场领先的TRACE品牌、其Pure Treatment自然健康和健康电子商务平台、其完全许可的加拿大大麻制造和分销网络以及与美国头号大麻饮料公司Keef Brands的合作伙伴关系,拥有3000多个零售分销点。
Forward-Looking Disclaimer
前瞻性免责声明
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: the prospective synergies between the business of BevCanna and Embark and the business of the Company following the closing of the acquisition of Embark; forecasted revenues of the Company in the fourth quarter of 2021 and for the financial year ended December 31, 2022; future product offerings; the potential benefits of various commercial agreements and partnerships; and other statements regarding the business of the Company. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements.
本新闻稿包含前瞻性陈述。除涉及公司相信、预期或预期未来将发生或可能发生的活动、事件或发展的历史事实陈述外,所有陈述均为前瞻性陈述。本新闻稿中的前瞻性陈述包括有关以下方面的陈述:完成对Bookk的收购后,BevCanna和Bookk的业务与公司业务之间的预期协同作用;公司在2021年第四季度和截至2022年12月31日的财政年度的预测收入;未来的产品供应;各种商业协议和伙伴关系的潜在好处;以及有关公司业务的其他陈述。前瞻性陈述反映了管理层基于现有信息的当前预期,可能会受到一些风险和不确定因素的影响,这些风险和不确定因素可能导致结果与前瞻性陈述中讨论的大不相同。
Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include, among other things: that the CSE may not approve the acquisition of Embark as proposed or at all; that the parties may not be able to satisfy the conditions to closing of the acquisition of Embark; general market conditions; risks associated with the COVID-19 pandemic; and other factors beyond the control of the parties. BevCanna expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.
尽管公司认为前瞻性陈述中固有的假设是合理的,但前瞻性陈述并不能保证未来的业绩,因此,由于这些陈述固有的不确定性,不应过分依赖它们。可能导致实际结果或事件与当前预期存在实质性差异的因素包括,但不限于:CSE可能不批准或根本不批准FOUNK收购;双方可能无法满足完成收购的条件;一般市场状况;与新冠肺炎疫情相关的风险;以及其他各方无法控制的因素。除适用法律要求外,BevCanna明确不承担任何因新信息、未来事件或其他原因而更新或修改任何前瞻性陈述的意图或义务,公司不承担任何与本文提及的任何其他公司相关的披露责任。
On behalf of the Board of Directors:
John Campbell, Chief Financial Officer and Chief Strategy Officer
Director, BevCanna Enterprises Inc.
我谨代表董事会:
约翰·坎贝尔,首席财务官兼首席战略官
BevCanna企业公司董事
For investor enquiries, please contact:
Shannon Devine, MZ North America
203-741-8811
BVNNF@mzgroup.us
如有投资者查询,请联络:
香农·迪瓦恩(Shannon Devine),MZ北美
203-741-8811
邮箱:bvnf@mzgroup.us
For media enquiries or interviews, please contact:
Wynn Theriault, Thirty Dash Communications Inc.
416-710-3370
wynn@thirtydash.ca
如欲查询或接受采访,请联络:
Wynn Theriault,Thirty Dash Communications Inc.
416-710-3370
邮箱:wynn@Thirtydash.ca